The mechanistic understanding of pathophysiological pathways underlying cardiac arrhythmias has advanced profoundly, opening up novel avenues for mechanism-based therapeutic approaches
[DOI] [PubMed] Costa A, Reyns B, Konieczna J, Martn M, Fiol M, Palou A, et al
Em.: 420460 nm), CMFDA (Ex.: 488 nm
[DOI] [PubMed] [Google Scholar] McLellan LI and Wolf CR
A well-characterized example is ezatiostat (TLK199)a GSH peptidomimetic moleculedesigned to display enhanced cellular uptake and whose metabolites bind the G-site of GSTP1-1 causing enzyme inhibition
[DOI] [PMC free article] [PubMed] [Google Scholar] 56.Aebersold DM, Kollar A, Beer KT, Laissue J, Greiner RH, Djonov V